Dear conference attendees and colleagues

Dear conference attendees and colleagues, it is a great privilege and pleasure to be a part of this important and prestigious International Ophthalmology Conference. To stay current with the latest advancements and discoveries in eye care, it's important to address this pressing and exciting challenge in a multi-stakeholder environment like this Meeting. The academicians and researchers attending IOC 2026 have the potential to benefit from the conference to manage activities in their respective areas by participating in this exchange. Since several neurodegenerative diseases, including glaucoma, involve retina damage, there is a pressing need for innovative neuroprotection approaches. The development and assessment of novel therapeutic strategies to counteract adverse effects of symptomatic treatments requires the use of reliable experimental models to mimic the underlying mechanisms of such eye diseases.

In my view, this IOC 2026 meeting will be a highly productive conference for engaging and motivating discussions and knowledge exchange, enabling to anticipate a future filled with innovative knowledge, research, and technology in ophthalmology issues, for reliable neuroprotective strategies.

Dear all our attendees

Following the superb meeting in Rome, it is great to see the IOC go from strength to strength. The conference brings together a skilful mix of subjects and expertise, and the organising committee are to be congratulated on putting together what promises to be an enlightening and educating event. It is increasingly difficult to run an ophthalmology conference that covers all the different disease topics, as our training and practice become ever more subspecialised. Yet, the need to look outside our silo remains ever important, and the more we share information across our respective areas, the more there is to gain. Hence, this conference remains as relevant as ever, perhaps even more so. So, from the front to back of the eye, whether virtual or in person, I expect there will be much to learn and enjoy in Singapore.

Dear congress attendees

Dear congress visitors, it is an honor and pleasure to write a few welcome notes. Ophthalmic drugs development has made tremendous progress for the last two decades. Today vision research is continually being transformed by new information and technologies. Many molecular technics, including gene therapy and mRNA technology, make unprecedented progress, to move forward to access to efficient innovative therapies to patients. Additionally, more advanced imaging modalities support our research. This opens new opportunities to prevent and treat blinding eye diseases. The IOC 2026 Scientific Conference will bring eye and vision scientists, researchers, health care professionals, advocacy groups, and patients, all involved in the development of new therapies for ophthalmic diseases, and aims at promising discussions on the latest advancements in Ophthalmology. Please, join us to enrich these discussions!

Dear Conference Attendees

Dear Conference Attendees,

Good morning, esteemed guests, it is an honor and great pleasure to write a few welcome notes for the session entitled "Optical Coherence Tomography Angiography – A Window into Retinal Health in Anemic Pregnant Women'. Anemia in pregnancy is a significant public health concern, and its impact on retinal health is a topic of growing interest. This keynote will explore the potential of OCTA in detecting retinal changes in anemic pregnant women, shedding light on the intricate relationship between anemia, pregnancy, and retinal health. For our young researchers, this talk promises to be a valuable learning experience, offering a unique perspective on the applications of OCTA in clinical research and practice. We'll gain insights into the latest techniques, challenges, and future directions in this field, and explore opportunities for innovation and discovery.

Dear distinguished delegates

Dear distinguished delegates,

It is my pleasure and honor to welcome you all to the International Ophthalmology Conference 2026 in Singapore. Ophthalmology is evolving every day with so many advancements worldwide. Gatherings like this help bringing new innovations and ideas together with diverse scientific discussions and collaborations in one forum. It helps to strengthen and improve our clinical practice so that we can improve patient’s outcomes globally. I am honored to learn from all the distinguished speakers and the participants from all over the world and wish everyone a very meaningful, rewarding and insightful conference ahead.